PRIOR PRINTER'S NOS. 225, 2895

PRINTER'S NO.  4139

  

THE GENERAL ASSEMBLY OF PENNSYLVANIA

  

HOUSE BILL

 

No.

272

Session of

2011

  

  

INTRODUCED BY HESS, BAKER, FLECK, MAJOR, CALTAGIRONE, CARROLL, CAUSER, COHEN, D. COSTA, J. EVANS, GOODMAN, GROVE, HARKINS, HARRIS, KAUFFMAN, M. K. KELLER, KIRKLAND, KORTZ, KOTIK, KULA, MAHONEY, MILLARD, PEIFER, PICKETT, RAPP, SWANGER, TALLMAN, YOUNGBLOOD, MOUL, BENNINGHOFF, MURT, KAVULICH, DENLINGER, BRADFORD, TRUITT, BRIGGS, MILLER, SCAVELLO, WATSON, GABLER, KILLION, FREEMAN, M. SMITH, HORNAMAN, HENNESSEY, R. BROWN, BEAR, PAYNE, CONKLIN, STEVENSON, PERRY, MAHER, ROCK, SAYLOR, HARPER AND BROOKS, JANUARY 27, 2011

  

  

AS AMENDED ON SECOND CONSIDERATION, HOUSE OF REPRESENTATIVES, OCTOBER 1, 2012   

  

  

  

AN ACT

  

1

Establishing a task force on Lyme disease and related maladies;

2

and providing for powers and duties of the task force, the

<--

3

Department of Health, the Department of Conservation and

4

Natural Resources and the Pennsylvania Game Commission and

5

for required coverage; and executing prevention and education

<--

6

strategies.

7

The General Assembly of the Commonwealth of Pennsylvania

8

hereby enacts as follows:

9

Section 1.  Short title.

<--

10

This act shall be known and may be cited as the Lyme and

11

Related Tick-Borne Disease Surveillance, Education, Prevention

12

and Treatment Act.

13

Section 2.  Findings.

14

The General Assembly finds and declares as follows:

15

(1)  Lyme disease and other tick-borne diseases are

16

carried primarily by ticks and pose a serious threat to the

 


1

quality of life of many citizens of this Commonwealth.

2

(2)  The most common way to acquire Lyme disease is to be

3

bitten by a tick that carries the spirochete.

4

(3)  The Centers for Disease Control and Prevention (CDC)

5

report that since 2001, Pennsylvania has ranked among the top

6

three states in the nation with the number of reported cases

7

of Lyme disease.

8

(4)  In 2009, 4,950 confirmed cases of Lyme disease were

9

reported in this Commonwealth, making Pennsylvania the

10

highest in the nation with reported cases of Lyme disease.

11

(5)  Lyme disease is most prevalent in southeastern

12

Pennsylvania, but it is found across this Commonwealth.

13

(6)  With proper precautions taken while engaged in

14

outdoor activities, people can greatly reduce their chances

15

of tick pathogen transmission by making sure that frequent

16

tick checks are made and ticks are removed and disposed of

17

promptly and properly.

18

(7)  The early clinical diagnosis and appropriate

19

treatment of these tick-borne disorders and diseases can

20

greatly reduce the risks of continued, diverse and chronic

21

signs and symptoms which can affect every system and organ of

22

the human body and often every aspect of life.

23

(8)  Left untreated, Lyme disease can cause a number of

24

signs and symptoms which can become quite severe.

25

(9)  Because the rate of progress of the disease and

26

differing individual responses to treatment, some patients

27

may have signs and symptoms that linger for months or even

28

years following treatment.

29

Section 3.  Definitions.

30

The following words and phrases when used in this act shall

- 2 -

 


1

have the meanings given to them in this section unless the

2

context clearly indicates otherwise:

3

"Board."  The Pennsylvania State Board of Medicine, the State

4

Board of Osteopathic Medicine and the State Board of Nursing.

5

"Department."  The Department of Health of the Commonwealth.

6

"Licensee."  A licensed physician or certified registered

7

nurse practitioner.

8

"Long-term antibiotic or antimicrobial therapy."

9

Administration of oral, intramuscular or intravenous antibiotics

10

or antimicrobial medications, singly or in combination, for

11

periods of more than four weeks.

12

"Lyme disease."  The clinical diagnosis of a patient by a

13

licensed physician or certified registered nurse practitioner of

14

the presence of signs or symptoms compatible with acute, late-

15

stage, persistent or chronic infection with Borrelia burgdorferi

16

or complications related to such infection or with such other

17

strains of Borrelia that are recognized by the Centers for

18

Disease Control and Prevention as a cause of Lyme disease. The

19

term includes infection which meets the surveillance criteria

20

set forth by the Centers for Disease Control and Prevention and

21

also includes other acute and chronic manifestations of such an

22

infection as determined by a physician.

23

"Other health impairment."  As defined by the Individuals

24

with Disabilities Education Act (Public Law 91-230, 20 U.S.C. §

25

1400 et seq.).

26

"Related tick-borne illnesses."  Cases of Bartonellosis,

27

Babesiosis/Piroplasmosis, Anaplasmosis, Ehrlichiosis and other

28

tick-transmissible illnesses as may be empirically associated

29

with Lyme disease.

30

"Surveillance case definitions."  The Case Definitions for

- 3 -

 


1

Public Health Surveillance, published by the Centers for Disease

2

Control and Prevention, which provide uniform criteria for

3

reporting cases to increase the specificity of reporting and

4

improving the comparability of diseases reported from different

5

geographic areas. As further noted by the CDC, surveillance case

6

definitions establish uniform criteria for disease reporting and

7

should not be used as the sole criteria for establishing

8

clinical diagnoses, determining the standard of care necessary

9

for a particular patient, setting guidelines for quality

10

assurance or providing standards for reimbursement.

11

"Therapeutic purpose."  The use of antibiotics to control a

12

patient's symptoms or signs determined by a physician as

13

reasonably related to Lyme disease and its sequelae or related

14

tick-borne illnesses.

15

Section 4.  Task force.

16

(a)  Establishment.--The department shall establish, to the

17

extent funds are appropriated specifically for the purposes of

18

this act, a task force on Lyme disease and related tick-borne

19

diseases.

20

(a.1)  Funding.--The department shall identify and apply for

21

public and private grants and funding in order to carry out the

22

requirements of this act to establish the task force.

23

(b)  Purpose.--The task force shall investigate and make

24

recommendations to the department regarding:

25

(1)  The surveillance and prevention of Lyme disease and

26

associated tick-borne diseases in this Commonwealth.

27

(2)  Raising awareness about the long-term effects of the

28

misdiagnosis of Lyme disease.

29

(3)  The development of a program of general public and

30

health care professional information and education regarding

- 4 -

 


1

Lyme disease which shall include the broad spectrum of

2

scientific and treatment views regarding Lyme disease and

3

related tick-borne illnesses, including evidence-based,

4

multiple standards of care and their respective evidence

5

bases for all stages of Lyme disease and related tick-borne

6

illnesses.

7

(4)  Cooperation with the Pennsylvania Game Commission to

8

disseminate the information required under paragraph (3) to

9

licensees of the commission and the general public.

10

(5)  Cooperation with the Department of Conservation and

11

Natural Resources to disseminate the information required

12

under paragraph (3) to the general public and visitors of

13

State parks and lands.

14

(6)  Cooperation with the Department of Environmental

15

Protection to test ticks for Lyme disease and other tick-

16

borne infections and provide results, including infection

17

rates across this Commonwealth, on their public Internet

18

website.

19

(7)  Cooperation with the Department of Education to:

20

(i)  Disseminate the information required under

21

paragraph (3) to school administrators, faculty, staff,

22

parents, guardians and students.

23

(ii)  Determine the role schools may play in the

24

prevention of Lyme disease, including, but not limited

25

to, prompt removal and reporting of tick removals to

26

State officials.

27

(iii)  Review and update policies to recognize

28

chronic Lyme disease and related tick-borne illnesses as

29

"other health impairment."

30

(c)  Composition.--The task force shall be composed of the

- 5 -

 


1

following individuals:

2

(1)  The Secretary of Health or a designee.

3

(2)  The Insurance Commissioner or a designee.

4

(3)  The Secretary of Education or a designee.

5

(4)  The Deputy Secretary for Conservation and

6

Engineering Services in the Department of Conservation and

7

Natural Resources or a designee.

8

(5)  The Director of the Bureau of Information and

9

Education of the Pennsylvania Game Commission or a designee.

10

(6)  Two physicians, with at least one licensed in this

11

Commonwealth, who are knowledgeable concerning treatment of

12

early, late-stage and chronic/persistent Lyme disease and who

13

are members of the International Lyme and Associated Diseases

14

Society.

15

(7)  One physician licensed in this Commonwealth who is

16

knowledgeable concerning treatment of early, late-stage and

17

chronic/persistent Lyme disease and who specializes in

18

infectious diseases.

19

(8)  One physician licensed in this Commonwealth who is

20

knowledgeable concerning treatment of early, late-stage and

21

chronic/persistent Lyme disease and who specializes in

22

neurology.

23

(9)  An epidemiologist licensed in this Commonwealth

24

having expertise in spirochetes and related infectious

25

diseases.

26

(10)  Two individuals representing Lyme disease support

27

groups.

28

(11)  One individual who is a Lyme disease patient or a

29

family member of a patient.

30

(12)  Two registered nurses licensed in this

- 6 -

 


1

Commonwealth, one of which should be a certified registered

2

nurse practitioner.

3

(13)  The Director of Vector Management of the Department

4

of Environmental Protection.

5

(14)  An entomologist who has experience in tick

6

identification and tick-borne diseases.

7

(15)  Two practitioners of veterinary medicine with at

8

least one licensed in this Commonwealth with experience in

9

tick-borne diseases.

10

(d)  Convening.--

11

(1)  Within 45 days of the effective date of this act,

12

the Secretary of Health shall appoint the members of the task

13

force. The Secretary of Health shall appoint a chairman of

14

the task force.

15

(2)  The task force shall convene within 90 days of the

16

effective date of this act and shall meet quarterly.

17

(3)  The task force shall issue a report with

18

recommendations to the Secretary of Health within one year of

19

its first meeting. The report shall also be transmitted to

20

the relevant committees of the House of Representatives.

21

Nothing in this act shall prohibit the task force from making

22

interim reports, taking agreed-upon immediate actions or

23

responding to requests for such reports.

24

(e)  Compensation and expenses.--The members of the task

25

force shall receive no compensation for their services but shall

26

be reimbursed for actual and necessary expenses incurred in

27

performance of their duties. Reimbursement shall be provided by

28

the department.

29

(f)  Department.--The department shall, to the extent funds

30

are appropriated specifically for the purposes of this act, have

- 7 -

 


1

the following powers and duties:

2

(1)  Develop a program of general public, health care

3

professional and governmental agency information and

4

education regarding Lyme disease which shall include the

5

broad spectrum of scientific and treating views regarding

6

Lyme disease and related tick-borne illnesses, including

7

multiple standards of care available for all stages of Lyme

8

disease and related tick-borne illnesses.

9

(2)  Develop an intensive program, including active

10

population-based surveillance, active tick surveillance and

11

sentinel (nonhuman) data to provide a better understanding of

12

diseases, geographic hot spots and infectivity to be used in

13

targeting prevention and education efforts.

14

(3)  Cooperate with the Pennsylvania Game Commission to

15

disseminate the information required under paragraph (1) to

16

licensees of the Pennsylvania Game Commission and the general

17

public.

18

(4)  Cooperate with the Department of Conservation and

19

Natural Resources to disseminate the information required

20

under paragraph (1) to the general public and visitors of

21

State parks and lands.

22

(5)  Cooperate with the professional associations of

23

health care professionals to provide the education program

24

for professionals required under paragraph (1).

25

(6)  Cooperate with the Department of Education to:

26

(i)  Disseminate the information under paragraph (1)

27

to school administrators, school nurses, faculty and

28

staff, parents, guardians and students.

29

(ii)  Determine what role schools may play in the

30

prevention of Lyme disease, including, but not limited

- 8 -

 


1

to, prompt removal and reporting of tick removals to

2

parents, guardians and State officials.

3

(iii)  Review and update policies to recognize

4

chronic Lyme disease and related tick-borne illnesses as

5

"other health impairment" potentially requiring

6

accommodations.

7

Section 5.  Required coverage.

8

(a)  Tick-borne illnesses.--Except as provided in subsection

9

(b), every health care policy which is delivered, issued for

10

delivery, renewed, extended or modified in this Commonwealth by

11

a health insurer must cover prescribed treatment for Lyme

12

disease or related tick-borne illnesses if the diagnosis and

13

treatment plan are documented in the patient's medical record, 

14

and it is documented in the patient's medical record that the

15

patient has been properly informed of multiple standards of

16

care, risks and benefits and able to exercise informed consent.

17

Such treatment plans may include long-term therapies, long-term

18

antibiotic or antimicrobial therapy and treatment as prescribed

19

by the patient's attending physician.

20

(b)  Exception.--Subsection (a) shall not apply to any of the

21

following types of insurance:

22

(1)  Hospital indemnity.

23

(2)  Accident.

24

(3)  Specified disease.

25

(4)  Disability income.

26

(5)  Dental.

27

(6)  Vision.

28

(7)  Civilian Health and Medical Program of the Uniformed

29

Services (CHAMPUS) supplement.

30

(8)  Medicare supplement.

- 9 -

 


1

(9)  Long-term care.

2

(10)  Other limited insurance benefit plans.

3

Section 20.  Effective date.

4

This act shall take effect immediately.

5

Section 1.  Short title.

<--

6

This act shall be known and may be cited as the Lyme and

7

Related Tick-Borne Disease Surveillance, Education, Prevention

8

and Treatment Act.

9

Section 2.  Findings.

10

The General Assembly finds and declares as follows:

11

(1)  Lyme disease and other tick-borne diseases are

12

carried primarily by ticks and pose a serious threat to the

13

health and quality of life of many citizens of this

14

Commonwealth.

15

(2)  The most common way to acquire Lyme disease is to be

16

bitten by a tick that carries the spirochete.

17

(3)  In 2009, 5,722 confirmed cases of Lyme disease were

18

reported in this Commonwealth, the highest number of cases

19

reported in any state and representing a 76% increase since

20

2006. In 2011, provisional numbers of 7,484 cases confirm

21

this ongoing upward trend.

22

(4)  These trends illustrate the World Health

23

Organization's (WHO) projections through 2010. The WHO states

24

that Lyme disease will increasingly become a public health

25

threat in the United States. Pennsylvania needs to be

26

prepared to deal with this trend, which is already being

27

observed in Pennsylvania's statistics.

28

(5)  Lyme disease is most prevalent in southeastern

29

Pennsylvania, but it is found across this Commonwealth.

30

(6)  With proper precautions taken while engaged in

- 10 -

 


1

outdoor activities, people can greatly reduce their chances

2

of tick pathogen transmission by making sure that frequent

3

tick checks are made and ticks are removed and disposed of

4

promptly and properly.

5

(7)  The early clinical diagnosis and appropriate

6

treatment of these tick-borne disorders and diseases can

7

greatly reduce the risks of continued symptoms which can

8

affect every system and organ of the human body and often

9

every aspect of life.

10

(8)  Left untreated, Lyme disease can cause a number of

11

signs and symptoms which can become quite severe.

12

Section 3.  Legislative intent.

13

It is the intent of the General Assembly:

14

(1)  To provide the public with information and education

15

to create greater public awareness of the dangers of and

16

measures available to prevent, diagnose and treat Lyme

17

disease and related maladies.

18

(2)  To ensure that:

19

(i)  Licensees, insurers, patients and governmental

20

agencies are educated about treatment options.

21

(ii)  Licensees provide patients with sufficient

22

information about treatment options to enable patients to

23

make an informed choice as part of informed consent and

24

respect the autonomy of that choice.

25

(iii)  Pennsylvania government agencies provide

26

unbiased information regarding treatment options.

27

Section 4.  Definitions.

28

The following words and phrases when used in this act shall

29

have the meanings given to them in this section unless the

30

context clearly indicates otherwise:

- 11 -

 


1

"Board."  The Pennsylvania State Board of Medicine, the State

2

Board of Osteopathic Medicine and the State Board of Nursing.

3

"Department."  The Department of Health of the Commonwealth.

4

"Licensee."  A licensed physician, a physician's assistant or

5

certified registered nurse practitioner or other licensed health

6

care professional.

7

"Long-term antibiotic or antimicrobial therapy."

8

Administration of oral, intramuscular or intravenous antibiotics

9

or antimicrobial medications, singly or in combination, for

10

periods of more than four weeks.

11

"Lyme disease."  The clinical diagnosis of a patient by a

12

licensed physician or certified registered nurse practitioner of

13

the presence of signs or symptoms compatible with acute, late-

14

stage, persistent infection with Borrelia burgdorferi or

15

complications related to such infection or with such other

16

strains of Borrelia that are recognized by the Centers for

17

Disease Control and Prevention as a cause of Lyme disease. The

18

term includes infection which meets the surveillance criteria

19

set forth by the Centers for Disease Control and Prevention and

20

other acute and persistent manifestations of such an infection

21

as determined by a physician.

22

"Related tick-borne illnesses."  Cases of Bartonellosis,

23

Babesiosis/Piroplasmosis, Anaplasmosis, Ehrlichiosis and other

24

tick-transmissible illnesses as may be empirically associated

25

with Lyme disease.

26

"Secretary."  The Secretary of Health of the Commonwealth.

27

"State officials."  The term includes the Secretary of

28

Environmental Protection.

29

"Task force."  The task force established by this act.

30

"Therapeutic purpose."  The use of antibiotics to control a

- 12 -

 


1

patient's symptoms or signs determined by a physician as

2

reasonably related to Lyme disease and its sequelae or related

3

tick-borne illnesses.

4

Section 5.  Task force.

5

(a)  Establishment.--The department shall establish a task

6

force on Lyme disease and related tick-borne diseases.

7

(b)  Purpose.--The task force shall investigate and make

8

recommendations to the department regarding:

9

(1)  The surveillance and prevention of Lyme disease and

10

related tick-borne illnesses in this Commonwealth.

11

(2)  Raising awareness about the long-term effects of the

12

misdiagnosis of Lyme disease.

13

(3)  The development of a program of general public and

14

health care professional information and education regarding

15

Lyme disease which shall include the broad spectrum of

16

scientific and treatment options regarding all stages of Lyme

17

disease and related tick-borne illnesses.

18

(4)  Cooperation with the Pennsylvania Game Commission to

19

disseminate the information required under paragraph (3) to

20

licensees of the commission and the general public.

21

(5)  Cooperation with the Department of Conservation and

22

Natural Resources to disseminate the information required

23

under paragraph (3) to the general public and visitors of

24

State parks and lands.

25

(6)  Cooperation with the Department of Environmental

26

Protection to test ticks and provide results and to publish

27

on its publicly accessible Internet website.

28

(7)  Cooperation with the Department of Education to:

29

(i)  Disseminate the information required under

30

paragraph (3) to school administrators, faculty, staff,

- 13 -

 


1

parents, guardians and students.

2

(ii)  Determine the role schools may play in the

3

prevention of Lyme disease, including, but not limited

4

to, prompt removal and reporting of tick removals to

5

State officials.

6

(iii)  Update policies to recognize signs or symptoms

7

of Lyme disease and related tick-borne illnesses as

8

health impairments potentially requiring accommodations.

9

(c)  Composition.--The task force shall be composed of the

10

following individuals:

11

(1)  The Secretary of Health or a designee.

12

(2)  The Insurance Commissioner or a designee.

13

(3)  The Secretary of Education or a designee.

14

(4)  The Deputy Secretary for Parks and Forestry in the

15

Department of Conservation and Natural Resources or a

16

designee.

17

(5)  The Director of the Bureau of Information and

18

Education of the Pennsylvania Game Commission or a designee.

19

(6)  Two physicians licensed in this Commonwealth, who

20

are knowledgeable concerning treatment of Lyme disease and

21

related tick-borne illnesses and who are members of the

22

International Lyme and Associated Diseases Society.

23

(7)  Two physicians licensed in this Commonwealth who are

24

knowledgeable concerning treatment of Lyme disease and

25

related tick-borne illnesses who are members of the

26

Infectious Disease Society of America.

27

(8)  An epidemiologist licensed in this Commonwealth

28

having expertise in spirochetes and related infectious

29

diseases.

30

(9)  Two individuals representing Lyme disease patient

- 14 -

 


1

groups who may be a Lyme disease patient of a family member

2

of a Lyme disease patient.

3

(10)  One individual who is a Lyme disease patient or a

4

family member of a Lyme disease patient.

5

(11)  Two registered nurses licensed in this

6

Commonwealth, one of which should be a certified registered

7

nurse practitioner and both of whom are knowledgeable

8

concerning Lyme disease and related tick-borne illnesses.

9

(12)  The Director of Vector Management of the Department

10

of Environmental Protection.

11

(13)  An entomologist with the Department of Entomology

12

of The Pennsylvania State University who has experience in

13

tick identification and tick-borne diseases.

14

(14)  A registered school nurse licensed in this

15

Commonwealth who is knowledgeable concerning Lyme disease and

16

tick-borne illnesses.

17

(15)  Two veterinarians licensed in this Commonwealth, at

18

least one of whom is a veterinary epidemiologist and both of

19

whom are knowledgeable concerning Lyme disease and related

20

tick-borne illnesses.

21

(d)  Meetings.--

22

(1)  Within 45 days of the effective date of this act,

23

the Secretary of Health shall appoint the members of the task

24

force. The Secretary of Health shall appoint a chairman of

25

the task force.

26

(2)  The task force shall convene within 90 days of the

27

effective date of this act and shall meet quarterly.

28

(3)  The task force shall issue a report with

29

recommendations to the Secretary of Health within one year of

30

its first meeting. The report shall also be transmitted to

- 15 -

 


1

the relevant committees of the Senate and the House of

2

Representatives. Nothing in this act shall prohibit the task

3

force from making interim reports, taking agreed-upon

4

immediate actions or responding to requests for such reports.

5

(e)  Compensation and expenses.--The members of the task

6

force shall receive no compensation for their services but shall

7

be reimbursed for actual and necessary expenses incurred in

8

performance of their duties. Reimbursement shall be provided by

9

the department.

10

(f)  Department.--The department shall:

11

(1)  Develop a program of general public and health care

12

professional information and education regarding Lyme disease

13

which shall include the broad spectrum of scientific and

14

treating options regarding all stages of Lyme disease and

15

related tick-borne illnesses.

16

(2)  Develop an active tick collection, testing and

17

surveillance program in cooperation with the Department of

18

Environmental Protection to provide a better understanding

19

of, including, but not limited to, the full range of tick-

20

borne diseases, geographic hot spots and levels of

21

infectivity to be used in targeting prevention and education

22

efforts. This effort may include veterinary data on tick-

23

borne disease prevention, specifically dogs and horses and

24

other animals as the Centers for Disease Control and

25

Prevention have recommended.

26

(3)  Cooperate with the Pennsylvania Game Commission to

27

disseminate the information required under paragraph (1) to

28

licensees of the Pennsylvania Game Commission and the general

29

public.

30

(4)  Cooperate with the Department of Conservation and

- 16 -

 


1

Natural Resources to disseminate the information required

2

under paragraph (1) to the general public and visitors of

3

State parks and lands.

4

(5)  Cooperate with the professional associations of

5

health care professionals to provide the education program

6

for professionals required under paragraph (1).

7

(6)  Cooperate with the Department of Education to:

8

(i)  Disseminate the information under paragraph (1)

9

to school administrators, school nurses, faculty and

10

staff, parents, guardians and students.

11

(ii)  Determine what role schools may play in the

12

prevention of Lyme disease, including, but not limited

13

to, prompt removal and reporting of tick removals to

14

State officials.

15

(iii)  Update policies to recognize signs or symptoms

16

of Lyme disease and related tick-borne illnesses as

17

health conditions potentially requiring accommodations.

18

(7)  Cooperate with the Department of Environmental

19

Protection to publish and make available on its publicly

20

accessible Internet website the information developed under

21

paragraph (2) to health care professionals and the general

22

public.

23

(8)  Cooperate with The Pennsylvania State University,

24

Department of Entomology, Cooperative Extension Program for

25

Integrated Pest Management, to disseminate educational

26

resources about ticks, related diseases and integrated pest

27

management for disease prevention as required under paragraph

28

(1) to health care professionals and the general public.

29

(9)  Identify and apply for public and private funding in

30

order to carry out the provisions of this act.

- 17 -

 


1

Section 6.  Required coverage.

2

(a)  Tick-borne illnesses.--Except as provided in subsection

3

(b), every health care policy which is delivered, issued for

4

delivery, renewed, extended or modified in this Commonwealth by

5

a health insurer must cover prescribed treatment for Lyme

6

disease or related tick-borne illnesses if the diagnosis and

7

treatment plan are documented in the patient's medical record,

8

and it is documented in the patient's medical record that the

9

patient has been properly informed of multiple standards of

10

care, risks and benefits and able to exercise informed consent.

11

Such treatment plans may include long-term therapies, long-term

12

antibiotic or antimicrobial therapy and treatment as prescribed

13

by the patient's attending physician.

14

(b)  Exception.--Subsection (a) shall not apply to any of the

15

following types of insurance:

16

(1)  Hospital indemnity.

17

(2)  Accident.

18

(3)  Specified disease.

19

(4)  Disability income.

20

(5)  Dental.

21

(6)  Vision.

22

(7)  Civilian Health and Medical Program of the Uniformed

23

Services (CHAMPUS) supplement.

24

(8)  Medicare supplement.

25

(9)  Long-term care.

26

(10)  Other limited insurance benefit plans.

27

Section 7.  Effective date.

28

This act shall take EFFECT July 1, 2013.

- 18 -